Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(17%)
Results Posted
200%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_1
1
17%
Ph phase_2
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(2)

Detailed Status

unknown2
Completed1
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
N/A3 (60.0%)

Trials by Status

completed117%
recruiting117%
terminated117%
unknown233%
withdrawn117%

Recent Activity

1 active trials
Showing 5 of 6
completedphase_2

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

NCT03753659
recruiting

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

NCT03981497
terminatedphase_1

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

NCT02782715
unknownnot_applicable

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

NCT04640116
unknownnot_applicable

Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma

NCT03609268
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03753659Phase 2

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

Completed
NCT03981497

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Recruiting
NCT02782715Phase 1

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

Terminated
NCT04640116Not Applicable

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Unknown
NCT03609268Not Applicable

Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma

Unknown
NCT03168152Not Applicable

Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6